RxDoctor Payments DataLook up a doctor →

Olatunde Osofisan, DPM

Foot & Ankle Surgery · W Hempstead, NYNPI 1306129341

Payments from drug & device makers

$112,307in general payments, 2019–2025

Across 650 payments — averaging $172.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Royal Biologics, Inc.$53K
  • Stryker$19K
  • Novastep Inc.$11K
  • Cardiovascular Systems Inc.$5K
  • Treace Medical Concepts, Inc.$4K
  • Abbott$3K
  • plus $17K from 35 others

What the payments were for

  • Royalty or licence$8,5558%
  • Consulting fees$43,02538%
  • Speaking & faculty fees$2,1252%
  • Travel & lodging$17,56216%
  • Food & beverage$40,87736%
  • Education$1640%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$112,307 in reported general payments places this provider in the 95th percentile of 652 foot & ankle surgery providers in New York.

See all foot & ankle surgery providers in New York

Medicare billing

Part B allowed, 2024
$109,845
Medicare patients
195
Services billed
531

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate294$137,827
Doxepin Hcl154$114,703
Diflorasone Diacetate98$68,306
Caspofungin Acetate208$51,597
Budesonide ErBudesonide40$48,394
ErtaczoSertaconazole Nitrate24$40,273
Diclofenac Potassium13$28,952
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc95$23,848
Naproxen Sodium ErNaproxen Sodium17$19,666
Chlorpromazine Hcl21$16,667
Tavaborole48$12,489
Betamethasone Dipropionate62$11,921
Oxiconazole Nitrate20$10,517
Fluocinonide27$10,312
Diclofenac Epolamine15$9,229

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in W Hempstead

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →